Roivant Sciences Ltd

Common Name

Roivant Sciences

Country

United Kingdom

Sector

Healthcare

Industry

Biotechnology

Employees

750

Ticker

ROIV

Exchange

NASDAQ/NGS

Website

roivant.com

Description

Roivant Sciences Ltd is a biopharmaceutical company focused on developing and commercializing innovative therapies through a unique model that emphasizes rapid and efficient drug delivery. As a platfo... Show more

Income Statement Balance Sheet Group Entities

Roivant Sciences's Financial Statements Preview

Below are the financial statements of Roivant Sciences, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in millions of USD	2025 as of 2025-03-31	2024 as of 2024-03-31
Assets	—	—
Current assets	—	—
Cash and cash equivalents	2,715.41^a	6,494.95^a
Marketable securities	2,171.48^a	0^a
Other current assets	113.17^a	80.61^a
Current assets of discontinued operations	0^a	156.27^a
Total current assets	5,000.06^a	6,731.83^a
Property and equipment, net	12.06^a	15.32^a
Operating lease right-of-use assets	89.02^a	44^a
Investments measured at fair value	302.94^a	247.75^a
Other assets	32.86^a	37.7^a
Noncurrent assets of discontinued operations	0^a	145.88^a
Total assets	5,436.94^a	7,222.48^a
Liabilities and shareholders’ equity	—	—
Current liabilities	—	—
Accounts payable	23.69^a	14.03^a
Accrued expenses	114.29^a	119.42^a
Operating lease liabilities	9.84^a	8.97^a
Other current liabilities	1.58^a	13.94^a
Current liabilities of discontinued operations	0^a	110.41^a
Total current liabilities	149.41^a	266.76^a
Liability instruments measured at fair value	9.98^a	25.74^a
Operating lease liabilities, noncurrent	90.33^a	45.02^a
Other liabilities	0.02^a	2.49^a
Noncurrent liabilities of discontinued operations	0^a	433.95^a
Total liabilities	249.74^a	773.95^a
Shareholders’ equity	—	—
Common shares	0^a	0^a
Additional paid-in capital	4,562.11^a	5,396.49^a
Retained earnings	116.06^a	576.17^a
Accumulated other comprehensive income (loss)	9.44^a	-4.08^a
Shareholders’ equity attributable to Roivant Sciences Ltd.	4,687.61^a	5,968.58^a
Noncontrolling interests	499.59^a	479.95^a
Total shareholders’ equity	5,187.2^a	6,448.53^a
Total liabilities and shareholders’ equity	5,436.94^a	7,222.48^a

Download Data

Verified Sources Behind Roivant Sciences’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Roivant Sciences’s data sources below and access millions more through our Disclosure Search.

a. Roivant Sciences's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Roivant Sciences Ltd

Roivant Sciences's Financial Statements Preview

Verified Sources Behind Roivant Sciences’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Verona Pharma PLC

LivaNova PLC

AstraZeneca PLC

GSK plc

Smith & Nephew PLC

Haleon PLC